Carla Nester, MD, MSA, FASN, has been in practice for 18 years, and is a pediatric and adult nephrologist at the University of Iowa Stead Family Children's Hospital, where she specializes in compliment-mediated glomerular diseases.
Insights Into Iptacopan in C3 Glomerulopathy: Carla Nester, MD, MSA, FASN
Carla Nester, MD, MSA, FASN, is coinvestigator for the ongoing APPEAR-C3G trial (NCT04817618), data from which were used to support the FDA’s recent approval of iptacopan (Fabhalta; Novartis) in complement 3 glomerulopathy (C3G).